A Cure? California Biotech Firm Makes Explosive Announcement
(Tea Party 247) – While many tyrannical Democrat governors have threatened to keep their states on lockdown until there’s a “cure” for the coronavirus, it appears these threats might not be so scary if the recent announcement from a California biotech company bears any weight.
According to Fox News, Sorrento Therapeutics, based in San Diego, claims it has developed an antibody that prevents the coronavirus from entering 100% of healthy human cells in their petri dish experiments.
The STI-1499 is one of several antibodies planned to be combined in a cocktail drug that Sorrento is developing in collaboration with Mt Sinai School of Medicine in New York.
According to a press release, Sorrento said it could produce up to 200,000 doses of the antibody a month, meaning the drug could be available months before a vaccine for COVID-19 is developed.
The company has filed for emergency approval from the US Food and Drug Administration but has yet to receive a green light.
Sorrento’s stocks soared by almost 220 percent after their explosive announcement.
“We want to emphasize there is a cure,” Sorrento’s CEO, Dr. Henry Ji, told Fox News.
“There is a solution that works 100 percent,” he continued.
“If we have the neutralizing antibody in your body, you don’t need the social distancing. You can open up a society without fear.”
However, as the Daily Mail notes, this is a rather significant “if.”
Promising though its effects on the virus were in lab tests on human cells, the company can’t rightfully say that it has blocked the the infection in the human body.
The antibody has not yet been tested in people, so how it might behave inside the body and its potential side effects are totally unknown.
It comes the same day that the Trump administration’s social distancing guidelines to slow the spread are expiring, and as many states begin to reopen despite expert warnings that relaxing restrictions may trigger a devastating second wave of infections.
Sorrento’s drug, dubbed STI-1499 is one about a dozen antibodies – immune cells that neutralize pathogens like coronavirus – that the company discovered had some effect on coronavirus.
A cocktail of antibodies could act like a ‘protective shield’ for human cells, preventing the virus that causes COVID-19, SARS-CoV-2 – from entering them.
It blocks the virus from its primary doorway, a receptor on the surface of human cells, the ACE2 receptor.
“This puts its arms around the virus. It wraps around the virus and moves them out of the body,” Dr. Ji told Fox News of what he’s seen in lab experiments.
“When the antibody prevents a virus from entering a human cell, the virus cannot survive.
“If they cannot get into the cell, they cannot replicate. So it means that if we prevent the virus from getting the cell, the virus eventually dies out. The body clears out that virus.”
Several companies and universities around the world have been looking into the use of antibodies to treat the novel coronavirus.